Reuters logo
BRIEF-Beigene says expects decision in Q1 of 2017 from partner Merck KGaA on BGB-283
March 2, 2017 / 2:23 PM / 9 months ago

BRIEF-Beigene says expects decision in Q1 of 2017 from partner Merck KGaA on BGB-283

March 2 (Reuters) - Beigene Ltd

* Beigene says expects decision in Q1 of 2017 from partner Merck KGaA on continuation option to develop, commercialize BGB-283 outside China Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below